Crewe Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-207
Closed -$17.4K 865
2024
Q2
$17.4K Buy
+207
New +$17.4K ﹤0.01% 579